Concepedia

Arthur Kunz

AK

Statistics

Publications

16

Citations

1.3K

H-Index

16

Active since

1992

Affiliations

Pearl River Community College(Current)

Regeneron (United States)

Women's Health Research Institute

Arthur Kunz is an author at Pearl River Community College specializing in antibody-drug conjugates, oncology, and antibody-drug conjugate therapy.

Publications per year

1992–2021

16

Publications

16

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert et al. · Blood · 2003 · 356 citations · Full text

, , +11

Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

Julian Andreev, Nithya Thambi, Andrés E. Perez Bay et al. · Molecular Cancer Therapeutics · 2017 · 164 citations

, , +17

Potent and Specific Antitumor Efficacy of CMC-544, a CD22-Targeted Immunoconjugate of Calicheamicin, against Systemically Disseminated B-Cell Lymphoma

John F. DiJoseph, Mary E.P. Goad, Maureen Dougher et al. · Clinical Cancer Research · 2004 · 99 citations

, , +13

Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22

John F. DiJoseph, Andrew G. Popplewell, Simon Tickle et al. · Cancer Immunology Immunotherapy · 2004 · 88 citations · Full text

, , +14

Delineation of a Cellular Hierarchy in Lung Cancer Reveals an Oncofetal Antigen Expressed on Tumor-Initiating Cells

Marc Damelin, Kenneth G. Geles, Maximillian T. Follettie et al. · Cancer Research · 2011 · 81 citations

, , +16

1–5 of 16